Camden National Corp Files Q3 2024 10-Q
Ticker: CAC · Form: 10-Q · Filed: 2024-11-07T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, banking
TL;DR
Camden National Corp's Q3 2024 10-Q is in. Financials look solid.
AI Summary
Camden National Corporation filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position as a national commercial bank. Key financial data and operational updates for the third quarter of 2024 are presented.
Why It Matters
This filing provides investors and analysts with the latest financial health and performance indicators for Camden National Corporation, crucial for understanding its current market standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing for a publicly traded company, providing standard financial disclosures.
Key Players & Entities
- Camden National Corporation (company) — Filer of the 10-Q
- 20240930 (date) — End of the reporting period
- 20241107 (date) — Filing date
- 001-13227 (dollar_amount) — SEC File Number
FAQ
What is the primary business of Camden National Corporation?
Camden National Corporation is a national commercial bank, as indicated by its Standard Industrial Classification code [6021].
For what period is this 10-Q filing reporting?
This 10-Q filing reports for the period ending September 30, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on November 7, 2024.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Where is Camden National Corporation headquartered?
Camden National Corporation is headquartered at Two Elm St, Camden, ME 04843.
Filing Stats: 4,700 words · 19 min read · ~16 pages · Grade level 15.4 · Accepted 2024-11-07 10:03:29
Filing Documents
- cac-20240930.htm (10-Q) — 4368KB
- a093024exhibit311.htm (EX-31.1) — 15KB
- a093024exhibit312.htm (EX-31.2) — 15KB
- a093024exhibit321.htm (EX-32.1) — 6KB
- a093024exhibit322.htm (EX-32.2) — 6KB
- 0000750686-24-000262.txt ( ) — 19273KB
- cac-20240930.xsd (EX-101.SCH) — 64KB
- cac-20240930_cal.xml (EX-101.CAL) — 130KB
- cac-20240930_def.xml (EX-101.DEF) — 525KB
- cac-20240930_lab.xml (EX-101.LAB) — 879KB
- cac-20240930_pre.xml (EX-101.PRE) — 692KB
- cac-20240930_htm.xml (XML) — 4741KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS Consolidated Statements of Condition (unaudited) - September 30, 2024 and December 31, 2023 3 Consolidated Statements of Income (unaudited) - Three and Nine Months Ended September 30, 2024 and 2023 4 Consolidated Statements of Comprehensive Income (Loss) (unaudited) - Three and Nine Months Ended September 30, 2024 and 2023 5 Consolidated Statements of Changes in Shareholders' Equity (unaudited) - Three and Nine Months Ended September 30, 2024 and 2023 6 Consolidated Statements of Cash Flows (unaudited) - Nine Months Ended September 30, 2024 and 2023 7 Notes to the Unaudited Consolidated Financial Statements 8
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 44
QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK 77
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK 77
CONTROLS AND PROCEDURES 78
ITEM 4. CONTROLS AND PROCEDURES 78
OTHER INFORMATION
PART II. OTHER INFORMATION
LEGAL PROCEEDINGS 79
ITEM 1. LEGAL PROCEEDINGS 79
RISK FACTORS 79
ITEM 1A. RISK FACTORS 79
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 80
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 80
DEFAULTS UPON SENIOR SECURITIES 80
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 80
MINE SAFETY DISCLOSURES 80
ITEM 4. MINE SAFETY DISCLOSURES 80
OTHER INFORMATION 80
ITEM 5. OTHER INFORMATION 80
EXHIBITS 81
ITEM 6. EXHIBITS 81 SIGNATURES 82 2
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS CONSOLIDATED STATEMENTS OF CONDITION (unaudited) (In thousands, except number of shares) September 30, 2024 December 31, 2023 ASSETS Cash and due from banks $ 69,493 $ 77,649 Interest-bearing deposits in other banks (including restricted cash) 70,019 22,155 Total cash, cash equivalents and restricted cash 139,512 99,804 Investments: Trading securities 5,141 4,647 Available-for-sale securities, at fair value (amortized cost of $ 664,768 and $ 702,937 , respectively) 603,211 625,808 Held-to-maturity securities, at amortized cost (fair value of $ 500,619 and $ 510,595 , respectively) 526,251 544,931 Other investments 22,513 15,394 Total investments 1,157,116 1,190,780 Loans held for sale, at fair value (book value of $ 11,607 and $ 10,152 , respectively) 11,706 10,320 Loans 4,116,729 4,098,094 Less: allowance for credit losses on loans ( 35,414 ) ( 36,935 ) Net loans 4,081,315 4,061,159 Goodwill 94,697 94,697 Core deposit intangible assets 554 971 Bank-owned life insurance 103,587 101,501 Premises and equipment, net 35,776 35,049 Deferred tax assets 37,703 42,226 Other assets 83,214 77,999 Total assets $ 5,745,180 $ 5,714,506 LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities Deposits: Non-interest checking $ 940,702 $ 967,750 Interest checking 1,445,828 1,553,787 Savings and money market 1,466,541 1,364,401 Certificates of deposit 553,481 609,503 Brokered deposits 168,674 101,919 Total deposits 4,575,226 4,597,360 Short-term borrowings 516,336 485,607 Junior subordinated debentures 44,331 44,331 Accrued interest and other liabilities 79,387 92,144 Total liabilities 5,215,280 5,219,442 Commitments and Contingencies (Note 8) Shareholders' Equity Common stock, no par value: authorized 40,000,000 shares, issued and outstanding 14,577,218 and 14,565,952 on September 30, 2024 and December 31, 2023, respectively 116,072 115,602 Retained earnings 500,927 481,014 Accumulated other comprehensive loss